Press release
Ulcerative Colitis Therapeutics Analysis - Key Players Celgene, InDex Pharmaceuticals AB, Protalix Biotherapiutics
Ulcerative colitis is a chronic inflammatory disease, which basically affect colonic mucosa. The main identified symptoms of the disease are bloody diarrhea, abdominal cramps and fatigue. Some of the other symptoms include, fever, vomiting, anorexia, abdominal distension and bloating. The treatment approaches to this disease mostly include the use of small molecules and monoclonal antibodies, which are being developed to target and reduce the inflammatory mediators.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/ulcerative-colitis-pipeline-analysis/report-sample
*Major companies collaborate for the development of ulcerative colitis pipeline
The research found that different companies are engaged in the collaboration for ulcerative colitis. In June, 2015 Lycera Corp. and Celgene Corporation collaborated for the development of Lycera Corp. drug candidate for the treatment of ulcerative colitis. Celgene obtained the exclusive right to acquire Lycera upon conclusion of the option period or achievement by Lycera of pre-specified clinical milestones. During the option period, Lycera retained full control of its research and development programs.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=ulcerative-colitis-pipeline-analysis
*Novel and patented technologies for ulcerative colitis pipeline
The novel technologies are being used for ulcerative colitis drug candidates. Protalix Ltd. is using ProCellEx technology platform for their drug candidates. ProCellEx technology platform overcomes the weaknesses by offering significant production, regulatory and cost benefits.
Browse report at: https://www.psmarketresearch.com/market-analysis/ulcerative-colitis-pipeline-analysis
Some of the key players developing ulcerative colitis therapeutics include EA Pharma Co., Ltd., Celgene Corporation, InDex Pharmaceuticals AB and others.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ulcerative Colitis Therapeutics Analysis - Key Players Celgene, InDex Pharmaceuticals AB, Protalix Biotherapiutics here
News-ID: 1426101 • Views: …
More Releases from P&S Intelligence
Modular Automation Market Poised for Robust Growth Amid Industry 4.0 Transformat …
According to the latest market research study published by P&S Intelligence, the global modular automation market is on an impressive growth trajectory, expected to generate USD 6.3 billion in 2024 and expand at a CAGR of 8.7% to reach USD 12.1 billion by 2032. This surge is driven by rising demand for flexible, cost-efficient manufacturing solutions and the accelerating integration of Industry 4.0 technologies.
As manufacturing landscapes evolve with rapid changes…
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
More Releases for Lycera
Systemic Lupus Erythematosus Market Insights, Forecast to 2031 | F. Hoffmann-La …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Systemic Lupus Erythematosus , which includes a detailed analysis based on competitors and important market segments (2022-2030). The Global Systemic Lupus Erythematosus provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes…
Systemic Lupus Erythematosus Market Statistical Forecast, Trade Analysis 2022 - …
Newark, New Castle, USA Systemic Lupus Erythematosus Market Analysis 2022 | By Treatment Type (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs), by Route of Administration (Parenteral, Oral), and by Distribution Channel (Hospital Pharmacy, Online Pharmacy) Business Opportunities, Pricing Strategy, Forthcoming opportunities planning, Market-specific challenges, Globally Market Key Facts are coverd in this report by Growth Plus Reports | 100+ Report Pages
Systemic Lupus Erythematosus Market 2022 with 100+ Pages Report and enhance…
Post-Traumatic Stress Disorder (PTSD) Market to Witness Huge Growth by Key Playe …
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Post-Traumatic Stress Disorder (PTSD) market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This…
Systemic Lupus Erythematosus Treatment Market 2019 Companies included Lycera, My …
Global Systemic Lupus Erythematosus Treatment Market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the Market. The authors of…
Systemic Lupus Erythematosus Treatment Market 2019 Knowledge Report on Pfizer, R …
Global Systemic Lupus Erythematosus Treatment Market Statistical Overview Report 2019 gives an outstanding tool for market Survey, openings, and Vital key and strategic basic leadership. This report perceives that in this quickly advancing and competitive scenario, up-coming data on the basis of Market research execution and settles on basic choices for development and benefit. It gives data on Systemic Lupus Erythematosus Treatment Market trends and advancements and sheds light on…
Systemic Lupus Erythematosus Treatment Market Analysis 2019 On: Lycera, Mylan, S …
This report aims to examine the developments of Systemic Lupus Erythematosus Treatment Market including its market improvement, development, position and others. This report on the market offers explanatory knowledge on the market parts like dominating players, drivers and restraints, production, revenue, consumption, import and export, and the most effective development within the organization size, deployment type, inside, segmentation comprised throughout this analysis, also major the players have used various strategies…
